“…(2022, 2023) in two separate studies evaluated the differences between offender and non-offender SSD patients regarding psychiatric pr e scription patterns and illness-related factors ( 46 , 49 ). Also, ten studies analyzed the relationship between different rating tools scores and VB in patients with SSD ( 36 , 38 , 39 , 41 , 43 , 45 , 46 , 48 – 50 ), including the Brief Psychiatric Rating Scale (BPRS) ( 38 , 43 , 52 ), the Psychopathy Checklist: Screening Version (PCL-SV), the Historical, Clinical and Risk management (HCR-20) scale ( 38 , 53 ), The Barratt Impulsiveness Scale version 11 (BIS-11) ( 38 , 54 ), the Positive And Negative Symptom Scale (PANSS) ( 36 , 39 , 41 , 43 , 45 , 46 , 48 – 50 , 55 ), the Social Disability Screening Schedule (SDSS) ( 43 ), Insight and Treatment Attitude Questionnaire (ITAQ) ( 47 , 56 ), Family Adaptation, Partnership, Growth, Affection and Resolve (APGAR) ( 47 , 57 ), Social Support Rating Scale (SSRS) ( 47 , 58 ), and Family Burden Scale of Disease (FBS) ( 47 , 59 ). Furthermore, two studies evaluated neuroimaging data of patients as VB predictors, along with sociodemographic features.…”